Thioglycolic acid inhibits mouse oocyte maturation and affects chromosomal arrangement and spindle configuration

S Y Hou1, L Zhang, K Wu

  • 1Department of Nutrition and Food Hygiene, Harbin Medical University, Heilongjiang, China.

Insights

Thioglycolic acid (TGA) impairs in-vitro maturation of mouse oocytes, affecting polar body formation, chromosomal arrangement, and spindle configuration. This suggests TGA may interfere with key meiotic biochemical processes, leading to abnormal development.

Area of Science:

  • Reproductive Toxicology
  • Developmental Biology
  • Cell Biology

Background:

  • Thioglycolic acid (TGA) is a chemical compound with suspected reproductive toxicology.
  • Understanding the specific effects of TGA on oocyte maturation is crucial for assessing reproductive risks.

Purpose of the Study:

  • To investigate the precise effects of varying thioglycolic acid (TGA) concentrations on the in-vitro maturation of mouse oocytes.
  • To evaluate TGA's impact on oocyte nuclear status, chromosomal arrangement, and spindle configuration.

Main Methods:

  • Mouse oocytes were cultured with different doses of thioglycolic acid (TGA).
  • Nuclear status was assessed using an inverted microscope.
  • Chromosomal arrangement and spindle configuration were evaluated via immunofluorescence staining.

Main Results:

  • TGA significantly decreased the percentage of first polar body formation.
  • TGA did not affect germinal vesicle breakdown rates.
  • Abnormal chromosomal arrangements and spindle elongation were observed in TGA-treated oocytes.

Conclusions:

  • Thioglycolic acid (TGA) inhibits in-vitro maturation of mouse oocytes.
  • TGA adversely affects chromosomal arrangement and spindle configuration during oocyte maturation.
  • TGA likely interferes with essential meiotic biochemical processes, leading to aberrant oocyte development.

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...